降脂

  • 网络lipid lowering;lipid-lowering
降脂降脂
  1. 降脂治疗的首要目标是降低LDL-C。

    The primary target of lipid lowering therapy is LDL-C lowering .

  2. 在一些患者中还可见LDL或“坏胆固醇”增加,其中部分患者需要加用降脂药。

    Elevations in the LDL or bad cholesterol were also seen in some patients , some of whom required the addition of lipid lowering agents .

  3. 红萝卜,显神通,降压降脂有奇功。

    Carrots have magic power on lowering blood pressure and blood fat .

  4. 益糖康从抗DNA损伤、降糖、降脂三方面对糖尿病及其并发症进行治疗。

    Yi-Tang-Kang can prevent and cure diabetes and diabetes'complication by kata-amylaceum kata-lipin anti-damage of DNA .

  5. HPLC法测定复方首乌降脂胶囊中熊果酸的含量

    Determination of ursolic acid in gold theragran capsules by HPLC

  6. 强化降脂治疗对于急性冠状动脉综合征伴糖尿病患者是否有益?PROVEIT-TIMI22试验的结果

    Acute coronary syndromes and diabetes : Is intensive lipid lowering beneficial ? Results of the PROVE IT-TIMI 22 trial

  7. 2型糖尿病患者糖耐量正常一级亲属降脂治疗对胰岛B细胞功能的影响

    Effect of lipid-lowering treatment on the function of B islet cells in the first-order relatives with normal glucose tolerance of type 2 diabetes mellitus

  8. 应用补肾复方固本降脂丸治疗原发性高脂蛋白血症患者52例。治疗结果如下:固本降脂丸能显著降低血TG,治疗前后自身对照P<0.001;

    Constitution-consolidating and Lipoprotein-reducing Bolus was used in treatment of 52 cases of hyperlipoproteinemia .

  9. 最后采用试剂盒法检测大鼠血脂并采用荧光定量PCR方法对大鼠降脂基因的表达情况进行分析。

    Then detect rats blood lipid and reducing blood lipid gene expression level with blood lipid kit and fluorescence quantitative PCR methods .

  10. 降脂、抗凝药物预防激素所致股骨头骨细胞坏死、凋亡及对Bcl-2表达的影响

    Study on Antilipemic and Anticoagulant Preventing Necrosis and Apoptosis of Osteocytes in Steroid-induced Osteonecrosis of the Femoral Head

  11. 对照组给予ACS的一般治疗,不予任何降脂药;

    Control group just only accepted routine therapy of ACS except non-lipid-lowering drugs ;

  12. PSS有明显降脂效果,而ASA、TP无此作用。

    Serum lipid was significantly decreased by PSS , but not by ASA or TP ;

  13. 结果:造模动物口服降脂利肝颗粒后,动物的血清AST(谷草转氨酶),ALT(谷丙转氨酶)及其他肝功能指标明显下降。

    Result : The animals ' AST , ALT and other hepatic index decreased significantly .

  14. 目的:观察贝特类降脂药对2型糖尿病(DM)伴高三酰甘油血症患者的降脂作用及对脑血管病变的影响。

    Objective : To study the effect of fibrates on blood lipid and cerebral vessels in patients with NIDD .

  15. 明显降低慢性肾功能衰竭大鼠血压(P<0.01);产monacolink烟色红曲培养条件和降脂活性的研究

    Studies on the Cultivation Conditions and the Blood Lipids Reduction Function of Monascus Fuliginosus Producing Monacolin K

  16. 采用微胶囊化技术以月见草油、卵磷脂、维生素E生产具有调节血脂功能的复合降脂冲剂。

    Microencapsulated powder of evening primrose oil , lecithin and vitamin E , were developed as a health food with a serum lipid adjustment function by spraying dry technology .

  17. 方法将118例肾病综合征高脂血症患者随机分为3组,3组均行标准剂量激素和一般对症治疗,A组同时使用氟伐他汀,B组同时使用辛伐他汀,C组不用任何降脂药物。

    And to select suitable hydroxymethylglutaryl coenzyme A ( HMG CoA ) reductase inhibitors for clinic treatments . Methods 118 cases of patients with nephrotic syndrome accompanied by hyperlipemia were divided into 3 groups randomly .

  18. 目的观察阿托伐他汀(立普妥)10mg的降脂疗效及耐受性。

    Objective To observe treatment efficacy of 10 mg .

  19. Lp(a)水平不受饮食和降脂药物等影响。

    The serum LP ( a ) level was not influenced by lipid lowering drugs , diet and other factors .

  20. 结论:降脂益肝丸有明显的降低TCH、TG、ALT和恢复肝功能的作用。

    Conclusion : JYP had significant effect of decreasing TCH , TG , ALT and resuming the liver function .

  21. 结论UAP调脂治疗具有抗血管内皮炎症反应的作用,并独立于降脂之外。

    Conclusions Lipid lowering therapy in patients with UAP has antiinflammatory effect on vascular endothelium .

  22. 目的探讨防衰降脂中血清唾液酸(SA)测定的意义。

    Objective To determine the significance of the lever of serum sialic acid ( SA ) in the study of antiaging and decreasing serum lipid .

  23. 结论复合微量营养素硒、维生素E、维生素C和镁具有明显的降血脂作用,且降脂模式非常有利于预防AS,同时能降低TXA2PGI2值,提示具有抗血小板聚集和促血管扩张作用。

    Conclusion Micronutrient complex ( Se , VE , VC , and Mg ) has the lipid lowering effect and can decrease TXA 2 / PGI 2 ratio , which is beneficial to the prevention of atherosclerosis .

  24. 本病的治疗以激素及免疫抑制剂为主,辅以抗氧化剂、降脂药物、ACEI类药物及中药等。

    The main drug was glucocorticoid and immunity inhibitor , besides antioxidant , ACEI and some Chinese traditional medicine .

  25. 结果15天后高剂量组具有很好的降脂作用,TC下降达17.5%。

    The results indicate that high dosage group had a good regulation effect to the blood lipid after 15 - day administration , and TC was 17.5 % reduced .

  26. 过去针对DN的治疗,一直主要以控制血糖,减少蛋白尿,控制血压,降脂、控制饮食等方面为主。

    In the past , the mainly therapy are to reduce proteuria , control blood pressure , drop lipoids , control . meat and drink .

  27. 虎杖保肝降脂有效部位(EPC)制备工艺、质量控制方法及初步药效学研究

    Study on the Preparing Technique , Quality Control Method and Initial Pharmacodynamics of the Effective Liver Protection and Lipid-lowering Fraction ( EPC ) in Polygonum Cuspidatum

  28. 基础血脂水平对HMG-CoA还原酶抑制剂降脂作用的影响

    Relation between baseline lipid levels and effectiveness of HMG-CoA reductase inhibitors in patients with hyperlipidemia

  29. 肾移植术后高脂血症患者转化生长因子和受体mRNA表达及辛伐他汀降脂治疗对其影响

    The mRNA Expression of Transforming Growth Factor ( TGF ) β 1 and its Receptor TGF β R3 mRNA in Peripheral Monocyte Cells of Kidney Transplant Patients with Hyperlipidemia and the Influence of Treatment with Simvastatin

  30. 复方贞术调脂方基于HMG-CoA还原酶的降脂作用机制及药效物质基础研究

    Study of Hypolipidemic Mechanisms and Efficacy of the Compound Prescription of FTZ Based on the HMG-CoA Reductase